RxDoctor Payments Data

Gurpreet Singh

Queens, NYNPI 1659159481

Payments from drug & device makers

$3,969in general payments, 2019–2025

Across 154 payments — averaging $25.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$623
  • Incyte Corporation$471
  • Johnson & Johnson$438
  • UCB, Inc.$392
  • Regeneron Healthcare Solutions, Inc.$316
  • Novartis$291
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$3,88498%
  • Education$852%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate23$1,382
Ketoconazole26$266
Triamcinolone Acetonide28$199

Paid to pharmacies, not to this prescriber.

Where these figures come from

Is this you, or does something look wrong? →